Gnosco provides a CE-certified digital teledermatology solution called Dermicus for fast and secure diagnosis of skin cancer and wounds. Dermicus is used by health care professionals and the system involves a mobile phone, mobile app and a web-platform. Clinical data and images are rapidly and easily collected by using the phone and sent to specialists for assessment, diagnosis and advice for treatment.
Dermicus improves the patient experience with faster diagnosis and it increases communication and collaboration between the healthcare providers. In addition, Dermicus provides a continuous E-learning platform for doctors and nurses to enable the adoption of teledermatology and supporting transformational change within the healthcare system.
Some of the benefits experienced include efficiencies gained due to less physical referrals to specialists, reduced costs due to fewer excisions and most importantly, an improved patient experience due to faster diagnosis.
For more information about the company and products, please visit: www.dermicus.com and www.gnosco.se.